Home » Topics » BioWorld

BioWorld
RSS

NEUROGEN DRUG DEAL WITH PFIZER

Feb. 10, 1992

IMMUNEX REPORTS FIRST ANNUAL PROFIT

Feb. 7, 1992

NORMAL PATHWAY TO ALZHEIMER'S PLAQUE

Feb. 7, 1992

POSITIVE RESULTS FOR ALZA ANTI-FUNGAL

Feb. 7, 1992

GENSIA SUBSIDIARY GETS NDA APPROVAL

Feb. 7, 1992

BTG ACQUIRES POULTRY VACCINE TECHNOLOGY

Feb. 7, 1992

GENZYME DRUG GETS ORPHAN DESIGNATION

Feb. 7, 1992

AMBISOME NEWS ENCOURAGES COMPETITORS

Feb. 7, 1992

MUREX COMPLETES WELLCOME ADDITION

Feb. 7, 1992

IVAX STOCK SWAP WORTH $245 MILLION

Feb. 7, 1992

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...